Physician Assistant · Brooklyn, NY
NPI
1073897559
Since 2011
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
5303 8th Ave
Brooklyn, NY, 11220
Phone (718) 972-1777
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$327K
1,577 prescriptions
Company payments, 2025
$378
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Alvin He prescribed most often to Medicare patients was Pantoprazole Sodium, with 294 prescriptions and refills. In total Alvin He wrote 1,577 Medicare prescriptions that cost $327K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Pantoprazole Sodium Generic | 294 | 356 | 139 | $1,410 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 188 | 188 | 188 | $12K |
| Nexium Esomeprazole Magnesium | 136 | 144 | 54 | $39K |
| Lansoprazole Generic | 116 | 132 | 59 | $1,533 |
| Dicyclomine Hcl Generic | 111 | 117 | 74 | $652 |
| Famotidine Generic | 99 | 128 | 50 | $1,186 |
| Sucralfate Generic | 83 | 98 | 52 | $3,024 |
| Creon Lipase/Protease/Amylase | 63 | 83 | 36 | $108K |
| Omeprazole Generic | 58 | 60 | 23 | $504 |
| Linzess Linaclotide | 45 | 51 | 19 | $28K |
| Dexilant Dexlansoprazole | 31 | 31 | 11 | $8,993 |
| Esomeprazole Magnesium Generic | 29 | 31 | 15 | $415 |
| Hydrocortisone Generic | 27 | 27 | 13 | $255 |
| Dexlansoprazole Dr Dexlansoprazole | 26 | 32 | 14 | $4,668 |
| Amoxicillin Generic | 20 | 20 | 20 | $125 |
Brand drugs: 412 claims; generic drugs: 1,165 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alvin He $378 ($378 in general payments such as food, travel and fees) from 3 companies. The largest payer was Gilead Sciences, Inc. with $210.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.